metoprolol has been researched along with Bradyarrhythmia in 62 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the influence of paroxetine on metoprolol concentrations and its effect in patients treated for acute myocardial infarction (AMI) who are routinely given paroxetine as a co-treatment of depression." | 9.13 | Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI). ( Babak, S; Bergman, U; Bertilsson, L; Boldueva, S; Burbello, A; Goryachkina, K, 2008) |
"To report a sinus bradycardia induced by metoprolol and terbinafine drug-drug interaction and its management." | 7.81 | A metoprolol-terbinafine combination induced bradycardia. ( Bebawi, E; Brindamour, D; Doré, M; Frenette, AJ; Jouni, SS; Tessier, AA, 2015) |
"To estimate and compare the risk of emergent bradycardia associated with starting immediate-release (IR) and slow-release (SR) formulations of metoprolol." | 7.79 | Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol. ( Gonzales, M; Pletcher, MJ; Shin, J, 2013) |
"Large randomized trials have reported mixed results regarding the risk of bradycardia between metoprolol and carvedilol." | 7.79 | Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice. ( Pletcher, MJ; Shin, J, 2013) |
"5 mg of alprazolam daily for 1 year and with 50 mg of metoprolol daily for 15 days, presented to a facility elsewhere with presyncope and complete atrioventricular block." | 7.74 | Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine. ( Bekar, L; Cumurcu, BE; Onalan, O, 2008) |
" We report a case of this inhibition manifested by life-threatening bradycardia in a patient receiving a CYP2D6 substrate, metoprolol." | 7.73 | Profound metoprolol-induced bradycardia precipitated by acetaminophen-propoxyphene. ( Lang, L; Lehmann, DF; Marraffa, JM; Ong, G, 2006) |
"Bupropion is an increasingly prescribed agent to aid in smoking cessation." | 7.72 | Severe sinus bradycardia after initiation of bupropion therapy: a probable drug-drug interaction with metoprolol. ( Greene, JL; McCollum, DL; McGuire, DK, 2004) |
" In this presentation a case of bradycardia after co-administration of paroxetine and metoprolol is reported." | 7.69 | [Bradycardia after beginning therapy with metoprolol and paroxetine]. ( Häfele, M; Hauger, B; König, F; Löble, M; Wolfersdorf, M; Wössner, S, 1996) |
"Ivabradine is a selective bradycardic agent that inhibits hyperpolarization-activated cyclic nucleotide-gated (HCN) channels." | 5.51 | Ivabradine preserves dynamic sympathetic control of heart rate despite inducing significant bradycardia in rats. ( Hayama, Y; Kawada, T; Nishikawa, T; Shimizu, S; Shishido, T; Sugimachi, M; Uemura, K; Yamamoto, H, 2019) |
"To investigate the influence of paroxetine on metoprolol concentrations and its effect in patients treated for acute myocardial infarction (AMI) who are routinely given paroxetine as a co-treatment of depression." | 5.13 | Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI). ( Babak, S; Bergman, U; Bertilsson, L; Boldueva, S; Burbello, A; Goryachkina, K, 2008) |
"A clinically significant interaction between epinephrine or levonordefrin with nonselective beta-adrenergic blocking agents, although apparently rare in the dental setting, is potentially serious and can lead to significant hypertension with a concomitant reflex bradycardia." | 4.86 | Beta-adrenergic blocking agents and dental vasoconstrictors. ( Giannakopoulos, H; Hersh, EV, 2010) |
"Our findings suggest that neonates born to mothers exposed to β blockers in late pregnancy, including labetalol, are at elevated risk for neonatal hypoglycemia and bradycardia." | 3.83 | Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. ( Bateman, BT; Desai, RJ; Fischer, MA; Hernandez-Diaz, S; Huybrechts, KF; Maeda, A; Mogun, H; Patorno, E; Seely, EW, 2016) |
"To report a sinus bradycardia induced by metoprolol and terbinafine drug-drug interaction and its management." | 3.81 | A metoprolol-terbinafine combination induced bradycardia. ( Bebawi, E; Brindamour, D; Doré, M; Frenette, AJ; Jouni, SS; Tessier, AA, 2015) |
"To estimate and compare the risk of emergent bradycardia associated with starting immediate-release (IR) and slow-release (SR) formulations of metoprolol." | 3.79 | Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol. ( Gonzales, M; Pletcher, MJ; Shin, J, 2013) |
"Large randomized trials have reported mixed results regarding the risk of bradycardia between metoprolol and carvedilol." | 3.79 | Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice. ( Pletcher, MJ; Shin, J, 2013) |
"5 mg of alprazolam daily for 1 year and with 50 mg of metoprolol daily for 15 days, presented to a facility elsewhere with presyncope and complete atrioventricular block." | 3.74 | Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine. ( Bekar, L; Cumurcu, BE; Onalan, O, 2008) |
" We report a case of this inhibition manifested by life-threatening bradycardia in a patient receiving a CYP2D6 substrate, metoprolol." | 3.73 | Profound metoprolol-induced bradycardia precipitated by acetaminophen-propoxyphene. ( Lang, L; Lehmann, DF; Marraffa, JM; Ong, G, 2006) |
"The present study addressed possible alterations in the pharmacodynamic and pharmacokinetic properties of the beta1-adrenoceptor antagonist metoprolol in experimental hypertension induced by abdominal aortic coarctation (ACo)." | 3.72 | Pharmacokinetic-pharmacodynamic properties of metoprolol in chronic aortic coarctated rats. ( Di Verniero, C; Höcht, C; Opezzo, JA; Taira, CA, 2004) |
"Bupropion is an increasingly prescribed agent to aid in smoking cessation." | 3.72 | Severe sinus bradycardia after initiation of bupropion therapy: a probable drug-drug interaction with metoprolol. ( Greene, JL; McCollum, DL; McGuire, DK, 2004) |
" In the present study, we investigated the effect of a single bolus administration of L-NAME on blood pressure and heart rate monitored for one hour in anesthetized rats and the influence of vagotomy and beta1-receptor blocker metoprolol on the L-NAME induced bradycardia." | 3.71 | Inhibition of beta-1 receptor but not vagotomy can abolish the L-NAME evoked bradycardia in anesthetized rat. ( Bartha, J; Hably, C; Vág, J, 2002) |
" In this presentation a case of bradycardia after co-administration of paroxetine and metoprolol is reported." | 3.69 | [Bradycardia after beginning therapy with metoprolol and paroxetine]. ( Häfele, M; Hauger, B; König, F; Löble, M; Wolfersdorf, M; Wössner, S, 1996) |
"Three patients with ischaemic heart disease developed profound cardiac failure, hypotension and bradycardia during combined therapy with verapamil and beta-adrenergic blocking drugs." | 3.66 | Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases. ( Anderson, ST; Federman, J; Harper, RW; Laufer, E; Pitt, A; Wayne, VS, 1982) |
" The other cases published are: 1) 10 cases with oxprenolol (including 5 cases of coma and 4 deaths), 2) 9 cases with acebutolol (2 deaths) including 5 with studies of the kinetics of the product (1 personal case), 3) 7 cases with pindolol (no bradycardia, good prognosis), 4) 6 cases (1 personal) with metoprolol (4 cases of massive ingestion with 1 death), 5) 3 cases with alprenolol (1 death), 6) 4 cases with sotalol (2 cases of turned apex, 1 death), 7) 1 case with atenolol." | 3.66 | [Acute poisoning caused by beta blockers in the adult. Apropos of 7 cases]. ( Auzépy, P; Boukara, N; Giudicelli, JF; Richard, C, 1983) |
"Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy." | 2.71 | Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. ( Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A, 2004) |
"The incidence of arrhythmias was less after metoprolol." | 2.67 | Effect of pre-operative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy. ( Blom, L; Jakobsen, CJ, 1992) |
"Metoprolol-treated patients had an improvement in mean exercise capacity by 3 mets (p less than ." | 2.66 | Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. ( Engelmeier, RS; Gunnar, RM; O'Connell, JB; Rad, N; Scanlon, PJ; Walsh, R, 1985) |
"Amiodarone is an extremely potent drug which is effective for both supraventricular as well as ventricular arrhythmias." | 2.36 | New antiarrhythmic drugs. ( Hess, DS; Scheinman, MM, 1983) |
"Amiodarone use was associated with higher metoprolol concentrations following adjustment for different covariates (p = ." | 1.91 | Impact of amiodarone use on metoprolol concentrations, α-OH-metoprolol concentrations, metoprolol dosing and heart rate: A cross-sectional study. ( Busseuil, D; de Denus, S; Dubé, MP; Gaulin, MJ; Jutras, M; Leclair, G; Meloche, M; Mongrain, I; Oussaïd, E; Pilon, MO; Robert, S; Tardif, JC, 2023) |
" Insulin was infused for a total of approximately 37 hours, most of which was dosed at 10 U/kg/hour; following discontinuation, serial serum insulin levels were drawn and remained at supraphysiologic levels for at least 24 hours and well above reference range for multiple days thereafter." | 1.56 | Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report. ( Bangh, SA; Cole, JB; Corcoran, JN; Jacoby, KJ; Olives, TD, 2020) |
"Ivabradine is a selective bradycardic agent that inhibits hyperpolarization-activated cyclic nucleotide-gated (HCN) channels." | 1.51 | Ivabradine preserves dynamic sympathetic control of heart rate despite inducing significant bradycardia in rats. ( Hayama, Y; Kawada, T; Nishikawa, T; Shimizu, S; Shishido, T; Sugimachi, M; Uemura, K; Yamamoto, H, 2019) |
"Reflex tachycardia was greater during atropine than metoprolol blockade and the sum of the HR increase during selective blockade (21 and 22 bpm) was greater when compared with the control (no blockade, 16 +/- 2 vs 11 +/- 2 bpm)." | 1.29 | Autonomic nervous system control of the heart: endurance exercise training. ( Foresman, BH; Raven, PB; Shi, X; Stern, SA; Stevens, GH, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (22.58) | 18.7374 |
1990's | 10 (16.13) | 18.2507 |
2000's | 21 (33.87) | 29.6817 |
2010's | 12 (19.35) | 24.3611 |
2020's | 5 (8.06) | 2.80 |
Authors | Studies |
---|---|
Bannister, BE | 1 |
Parry, DR | 1 |
Pouliot, JD | 1 |
Xiao, SQ | 1 |
Ibarra, F | 1 |
Cruz, M | 1 |
Stone, KH | 1 |
Reynolds, K | 1 |
Davis, S | 1 |
Van Tassell, BW | 1 |
Gibson, CM | 1 |
Robert, S | 1 |
Pilon, MO | 1 |
Oussaïd, E | 1 |
Meloche, M | 1 |
Leclair, G | 1 |
Jutras, M | 1 |
Gaulin, MJ | 1 |
Mongrain, I | 1 |
Busseuil, D | 1 |
Tardif, JC | 2 |
Dubé, MP | 1 |
de Denus, S | 1 |
Corcoran, JN | 1 |
Jacoby, KJ | 1 |
Olives, TD | 1 |
Bangh, SA | 1 |
Cole, JB | 1 |
Muniyappa, A | 1 |
Goldschlager, N | 1 |
Calzadilla, A | 1 |
Badiye, A | 1 |
Ghodsizad, A | 1 |
Bernstein, J | 1 |
Campos, M | 1 |
Mirsaeidi, M | 1 |
Kawada, T | 1 |
Shimizu, S | 1 |
Uemura, K | 1 |
Hayama, Y | 1 |
Yamamoto, H | 1 |
Shishido, T | 1 |
Nishikawa, T | 1 |
Sugimachi, M | 1 |
Shin, J | 2 |
Gonzales, M | 1 |
Pletcher, MJ | 2 |
Bebawi, E | 1 |
Jouni, SS | 1 |
Tessier, AA | 1 |
Frenette, AJ | 1 |
Brindamour, D | 1 |
Doré, M | 1 |
Salomon, S | 1 |
Fausto, J | 1 |
Vaillant, F | 1 |
Lauzier, B | 1 |
Ruiz, M | 1 |
Shi, Y | 1 |
Lachance, D | 1 |
Rivard, ME | 1 |
Bolduc, V | 1 |
Thorin, E | 1 |
Des Rosiers, C | 1 |
Bahrainy, S | 1 |
Levy, WC | 1 |
Busey, JM | 1 |
Caldwell, JH | 1 |
Stratton, JR | 1 |
Bateman, BT | 1 |
Patorno, E | 1 |
Desai, RJ | 1 |
Seely, EW | 1 |
Mogun, H | 1 |
Maeda, A | 1 |
Fischer, MA | 1 |
Hernandez-Diaz, S | 1 |
Huybrechts, KF | 1 |
Caramelli, B | 1 |
Gualandro, DM | 1 |
Freitas, S | 1 |
Yu, PC | 1 |
Calderaro, D | 1 |
Keane, M | 1 |
Rolfo, F | 1 |
Bobbio, M | 1 |
Angeli, F | 1 |
Cavallini, C | 1 |
Lazebnik, LB | 1 |
Mikheeva, OM | 1 |
Drozdov, VN | 1 |
Petrakov, AV | 1 |
Sil'vestrova, SIu | 1 |
Alonso-Coello, P | 1 |
Alvarez, C | 1 |
Cruz, P | 1 |
Torán, L | 1 |
De Nadal, M | 1 |
Martínez, M | 1 |
Paniagua, P | 1 |
Mases, A | 1 |
Urrutia, G | 1 |
Hersh, EV | 1 |
Giannakopoulos, H | 1 |
Ramdas, S | 1 |
Riesenberg, LA | 1 |
Jasani, N | 1 |
Vág, J | 1 |
Hably, C | 1 |
Bartha, J | 1 |
Wnek, W | 1 |
Sia, S | 1 |
Ko, DT | 1 |
Hebert, PR | 1 |
Coffey, CS | 1 |
Curtis, JP | 1 |
Foody, JM | 1 |
Sedrakyan, A | 1 |
Krumholz, HM | 1 |
Höcht, C | 1 |
Di Verniero, C | 1 |
Opezzo, JA | 1 |
Taira, CA | 1 |
McCollum, DL | 1 |
Greene, JL | 1 |
McGuire, DK | 1 |
Steinwender, C | 1 |
Hofmann, R | 1 |
Kypta, A | 1 |
Leisch, F | 1 |
Marraffa, JM | 1 |
Lang, L | 1 |
Ong, G | 1 |
Lehmann, DF | 1 |
Thürmann, PA | 1 |
Haack, S | 1 |
Werner, U | 1 |
Szymanski, J | 1 |
Haase, G | 1 |
Drewelow, B | 1 |
Reimann, IR | 1 |
Hippius, M | 1 |
Siegmund, W | 1 |
May, K | 1 |
Hasford, J | 1 |
Triposkiadis, F | 1 |
Giamouzis, G | 1 |
Kelepeshis, G | 1 |
Sitafidis, G | 1 |
Skoularigis, J | 1 |
Demopoulos, V | 1 |
Goryachkina, K | 1 |
Burbello, A | 1 |
Boldueva, S | 1 |
Babak, S | 1 |
Bergman, U | 1 |
Bertilsson, L | 1 |
Sato, S | 1 |
Onalan, O | 1 |
Cumurcu, BE | 1 |
Bekar, L | 1 |
Weisswange, A | 3 |
Csapo, G | 2 |
Kalusche, D | 1 |
Keck, M | 1 |
Wayne, VS | 1 |
Harper, RW | 1 |
Laufer, E | 1 |
Federman, J | 1 |
Anderson, ST | 1 |
Pitt, A | 1 |
Auzépy, P | 1 |
Boukara, N | 1 |
Richard, C | 1 |
Giudicelli, JF | 1 |
Scheinman, MM | 1 |
Hess, DS | 1 |
Nylander, E | 2 |
Areskog, NH | 1 |
Roach, PJ | 1 |
Magee, MA | 1 |
Freedman, SB | 1 |
Sra, JS | 1 |
Jazayeri, MR | 1 |
Avitall, B | 1 |
Dhala, A | 1 |
Deshpande, S | 1 |
Blanck, Z | 1 |
Akhtar, M | 1 |
Shi, X | 1 |
Stevens, GH | 1 |
Foresman, BH | 1 |
Stern, SA | 1 |
Raven, PB | 1 |
König, F | 1 |
Häfele, M | 1 |
Hauger, B | 1 |
Löble, M | 1 |
Wössner, S | 1 |
Wolfersdorf, M | 1 |
Breithaupt-Grögler, K | 1 |
Gerhardt, G | 1 |
Lehmann, G | 1 |
Notter, T | 1 |
Belz, GG | 1 |
Liguori, GA | 1 |
Kahn, RL | 1 |
Gordon, J | 1 |
Gordon, MA | 1 |
Urban, MK | 1 |
Yörükoğlu, D | 1 |
Göktug, A | 1 |
Alanoğlu, Z | 1 |
Tulunay, M | 1 |
Roach , D | 1 |
Thakore , E | 1 |
Sheldon , R | 1 |
Teixeira, AL | 1 |
Fontoura, BF | 1 |
Freire-Maia, L | 1 |
Chiari, E | 1 |
Machado, CR | 1 |
Teixeira, MM | 1 |
Camargos, ER | 1 |
Lager, I | 1 |
Blohmé, G | 1 |
Smith, U | 1 |
Roskamm, H | 1 |
Boucher, M | 1 |
Chapuy, E | 1 |
Duchêne-Marullaz, P | 1 |
Dangovian, MI | 1 |
Jarandilla, R | 1 |
Frumin, H | 1 |
Jakobsen, CJ | 1 |
Blom, L | 1 |
Reggev, A | 1 |
Vollhardt, BR | 1 |
Ol'binskaia, LI | 1 |
Vartanova, OA | 1 |
Sinopal'nikov, AI | 1 |
Alekseev, VG | 1 |
Logunov, OV | 1 |
Leor, J | 1 |
Levartowsky, D | 1 |
Sharon, C | 1 |
Farfel, Z | 1 |
Engelmeier, RS | 1 |
O'Connell, JB | 1 |
Walsh, R | 1 |
Rad, N | 1 |
Scanlon, PJ | 1 |
Gunnar, RM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
2%-Mepivacaine With Two Different Vasoconstrictors; 1:20.000 Levonordefrin or 1:100.000 Epinephrin for Local Anesthesia in Third Molar Surgery: A Comparative Randomized Clinical Trial[NCT02603198] | 30 participants (Anticipated) | Interventional | 2014-08-31 | Active, not recruiting | |||
Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies[NCT03182777] | 31 participants (Actual) | Interventional | 2015-05-31 | Completed | |||
Predicting the Occurence of Hypotensive Bradycardic Events in the Patients Undergoing Arthroscopic Shoulder Surgery in the Sitting Position Under Interscalene Brachial Plexus Block[NCT01926561] | 68 participants (Actual) | Observational | 2011-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for metoprolol and Bradyarrhythmia
Article | Year |
---|---|
[The POISE study].
Topics: Adrenergic beta-Antagonists; Bradycardia; Delayed-Action Preparations; Heart Arrest; Humans; Hyperte | 2008 |
Beta-adrenergic blocking agents and dental vasoconstrictors.
Topics: Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthetics, Local; Bradycardia; Drug Interactions; | 2010 |
Beta-adrenergic blocking agents and dental vasoconstrictors.
Topics: Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthetics, Local; Bradycardia; Drug Interactions; | 2010 |
Beta-adrenergic blocking agents and dental vasoconstrictors.
Topics: Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthetics, Local; Bradycardia; Drug Interactions; | 2010 |
Beta-adrenergic blocking agents and dental vasoconstrictors.
Topics: Adrenergic beta-Antagonists; Anesthesia, Dental; Anesthetics, Local; Bradycardia; Drug Interactions; | 2010 |
New antiarrhythmic drugs.
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Blood Circulation; Bradycardia; Diltiazem; Half | 1983 |
12 trials available for metoprolol and Bradyarrhythmia
Article | Year |
---|---|
[Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs].
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bradycardi | 2008 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatig | 2004 |
Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Blood Pressure; Bradycardia; Cardiac Output, Low; Dose-Res | 2007 |
Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI).
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Area | 2008 |
Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 1998 |
The use of metoprolol and glycopyrrolate to prevent hypotensive/bradycardic events during shoulder arthroscopy in the sitting position under interscalene block.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arthroscopy; Bradycardia; Double-Blind Method; | 1998 |
Comparison of intravenous metoprolol, verapamil and diltiazem on the attenuation of haemodynamic changes associated with tracheal extubation.
Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Bradycardia; Diastole; Dilti | 1999 |
Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics.
Topics: Adult; Blood Glucose; Blood Pressure; Bradycardia; Clinical Trials as Topic; Diabetes Mellitus; Dias | 1979 |
Effect of pre-operative metoprolol on cardiovascular and catecholamine response and bleeding during hysterectomy.
Topics: Administration, Oral; Adult; Anesthesia Recovery Period; Anesthesia, General; Arrhythmias, Cardiac; | 1992 |
[Possibilities and limitations of selective beta 1 adrenergic receptor blockade in clinical practice].
Topics: Adult; Aged; Bradycardia; Bronchi; Bronchial Spasm; Clinical Trials as Topic; Coronary Disease; Dose | 1988 |
Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.
Topics: Adult; Bradycardia; Cardiomyopathy, Dilated; Clinical Trials as Topic; Exercise Test; Female; Heart | 1985 |
Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradycardia; Clinical Trials as Topic; Humans; Metopro | 1985 |
47 other studies available for metoprolol and Bradyarrhythmia
Article | Year |
---|---|
Clinically Significant Bradycardia and Hypotension Following Consumption of Betel Leaf in a Patient Treated for Chronic Atrial Fibrillation.
Topics: Aged; Atrial Fibrillation; Bradycardia; Diabetes Mellitus, Type 2; Female; Humans; Hypotension; Meto | 2023 |
Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation.
Topics: Atrial Fibrillation; Bradycardia; Calcium Channel Blockers; Diltiazem; Heart Rate; Humans; Hypotensi | 2022 |
Comparison of new-onset post-operative atrial fibrillation between patients receiving carvedilol and metoprolol after off-pump coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Bradycardia; Carvedilol; Coronary Artery By | 2023 |
Impact of amiodarone use on metoprolol concentrations, α-OH-metoprolol concentrations, metoprolol dosing and heart rate: A cross-sectional study.
Topics: Adult; Amiodarone; Bradycardia; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Heart Rate; Humans | 2023 |
Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report.
Topics: Adrenergic beta-1 Receptor Antagonists; Amlodipine; Bradycardia; Calcium Channel Blockers; Drug Admi | 2020 |
Wide Complex Ventricular Rhythm in a Patient After Collapse.
Topics: Aged, 80 and over; Antihypertensive Agents; Arrhythmias, Cardiac; Bradycardia; Electrocardiography; | 2017 |
A Young Woman with Bradycardia and Hypotension.
Topics: Adrenergic beta-1 Receptor Antagonists; Analgesics, Opioid; Benzodiazepines; Bradycardia; Central Ne | 2018 |
Ivabradine preserves dynamic sympathetic control of heart rate despite inducing significant bradycardia in rats.
Topics: Animals; Blood Pressure; Bradycardia; Heart Rate; Hyperpolarization-Activated Cyclic Nucleotide-Gate | 2019 |
Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Bradycardia; California; Databases, Factual; D | 2013 |
Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice.
Topics: Adrenergic alpha-1 Receptor Antagonists; Bradycardia; California; Carbazoles; Carvedilol; Comorbidit | 2013 |
A metoprolol-terbinafine combination induced bradycardia.
Topics: Bradycardia; Cytochrome P-450 CYP2D6; Drug Interactions; Drug Therapy, Combination; Heart Rate; Huma | 2015 |
Unnecessary pacemaker: care coordination problems and language barriers.
Topics: Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrioventricular Block; Bradycardia; Communic | 2015 |
Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Benzazepines; Bradycardia; Cardiovascular Agents; D | 2016 |
Exercise training bradycardia is largely explained by reduced intrinsic heart rate.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Adult; Age Factors; Aged; Autonomi | 2016 |
Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.
Topics: Adrenergic beta-Antagonists; Atenolol; Bradycardia; Cohort Studies; Female; Humans; Hypertension; Hy | 2016 |
Beta-blocker therapy in non-cardiac surgery.
Topics: Adrenergic beta-Antagonists; Bradycardia; Cardiovascular Diseases; Causality; Comorbidity; Humans; H | 2008 |
Beta-blocker therapy in non-cardiac surgery.
Topics: Adrenergic beta-Antagonists; Bradycardia; Cardiovascular Diseases; Delayed-Action Preparations; Huma | 2008 |
[Beta-blockers in patients undergoing noncardiac surgery: implications of the POISE study].
Topics: Adrenergic beta-Antagonists; Bradycardia; Contraindications; Female; Forecasting; Heart; Heart Arres | 2009 |
Drug overdose with refractory bradycardia and hypotension.
Topics: Antihypertensive Agents; Bradycardia; Clonazepam; Diltiazem; Drug Overdose; Female; GABA Modulators; | 2011 |
Inhibition of beta-1 receptor but not vagotomy can abolish the L-NAME evoked bradycardia in anesthetized rat.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anesthesia; Animals; Blood Pres | 2002 |
[The use of intra-aortic balloon counterpulsation in the treatment of severe hemodynamic instability from myocardial depressant drug overdose].
Topics: Adult; Antihypertensive Agents; Bradycardia; Counterpulsation; Diltiazem; Drug Overdose; Fatal Outco | 2003 |
Plasma concentrations of epinephrine need to be monitored in study of incidence of hypotensive/bradycardic events.
Topics: Bradycardia; Epinephrine; Humans; Hypotension; Intraoperative Complications; Metoprolol; Monitoring, | 2004 |
Pharmacokinetic-pharmacodynamic properties of metoprolol in chronic aortic coarctated rats.
Topics: Animals; Aortic Coarctation; Blood Pressure; Bradycardia; Chronic Disease; Disease Models, Animal; D | 2004 |
Severe sinus bradycardia after initiation of bupropion therapy: a probable drug-drug interaction with metoprolol.
Topics: Adrenergic beta-Antagonists; Arrhythmia, Sinus; Bradycardia; Bupropion; Dopamine Uptake Inhibitors; | 2004 |
Recurrent symptomatic bradycardia due to secret ingestion of beta-blockers--a rare manifestation of cardiac Münchhausen syndrome.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Bradycardia; Female; Humans; Metoprolol; M | 2005 |
Profound metoprolol-induced bradycardia precipitated by acetaminophen-propoxyphene.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Analgesics, Non-Narcotic; Analgesics, Opioid; Bradycardi | 2006 |
Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Bradycardia; Cytochrome P-450 CYP2D6; Dose-Res | 2006 |
Quantitative evaluation of ontogenetic change in heart rate and its autonomic regulation in newborn mice with the use of a noninvasive piezoelectric sensor.
Topics: Age Factors; Animals; Animals, Newborn; Atropine; Autonomic Nervous System; Baroreflex; Biosensing T | 2008 |
Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atrioventricular Block; Atrioventricular Node; | 2008 |
Electrophysiological studies with prenalterol.
Topics: Adrenergic beta-Agonists; Atrial Fibrillation; Atrioventricular Node; Bradycardia; Bundle of His; Ca | 1982 |
Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases.
Topics: Adrenergic beta-Antagonists; Aged; Bradycardia; Coronary Disease; Drug Interactions; Drug Therapy, C | 1982 |
[Acute poisoning caused by beta blockers in the adult. Apropos of 7 cases].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Alcohol Drinking; Bradycardia; Coma; Dos | 1983 |
New aspects on training bradycardia.
Topics: Adult; Animals; Bradycardia; Electrocardiography; Heart; Heart Rate; Humans; Hydroxydopamines; Metop | 1982 |
Asystole and bradycardia during dipyridamole stress testing in patients receiving beta blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Bradycardia; Dipyridamole; Electrocardiography; Exercise Test | 1993 |
Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Topics: Adolescent; Adult; Aged; Bradycardia; Cardiac Pacing, Artificial; Disopyramide; Female; Follow-Up St | 1993 |
Autonomic nervous system control of the heart: endurance exercise training.
Topics: Adult; Atropine; Autonomic Nervous System; Blood Volume; Bradycardia; Cholinergic Antagonists; Drug | 1995 |
[Bradycardia after beginning therapy with metoprolol and paroxetine].
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Blood Pressure; Bradycardia; | 1996 |
Beta-blockers for heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Heart Failure; Humans; | 2000 |
Origins of heart rate variability: autonomic blockade of large magnitude, transient bradycardia in conscious rabbits.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-2 Receptor An | 2001 |
Cardiac autonomic denervation and functional response to neurotoxins during acute experimental Chagas' disease in rats.
Topics: Acetylcholine; Animals; Atropine; Bradycardia; Chagas Cardiomyopathy; Denervation; Heart; Heart Rate | 2001 |
[Is bradycardia a contraindication?].
Topics: Adrenergic beta-Antagonists; Bradycardia; Heart Rate; Humans; Metoprolol | 1978 |
[Effect of beta-receptor blocking agent in 2nd degree av-block: conduction study in 9 patients (author's transl)].
Topics: Adolescent; Adult; Aged; Bradycardia; Electrocardiography; Female; Heart Block; Heart Conduction Sys | 1978 |
Membrane stabilizing activity and beta-adrenoceptor antagonist-induced bradycardia in conscious dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Function; Bradycardia; Consciousness; Dogs; Dose-Respon | 1992 |
Prolonged asystole during head-up tilt table testing after beta blockade.
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Female; Heart Arrest; Humans; Hypotension, Orthosta | 1992 |
Training-induced bradycardia in rats on cardioselective and non-selective beta receptor blockade.
Topics: Adrenergic beta-Antagonists; Animals; Bradycardia; Female; Heart Rate; Metoprolol; Physical Exertion | 1985 |
Bradycardia induced by an interaction between phenelzine and beta blockers.
Topics: Aged; Angina Pectoris; Bradycardia; Depressive Disorder; Drug Interactions; Drug Therapy, Combinatio | 1989 |
Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol.
Topics: Amiodarone; Atenolol; Bradycardia; Cardiomyopathy, Hypertrophic; Drug Interactions; Drug Therapy, Co | 1988 |